Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
延藜胶囊治疗功能性勃起功能障碍-肾阳虚证的随机、双盲、 安慰剂平行对照、多中心Ⅱ期(补充)临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II (supplementary) clinical trial of Yanli Capsule in the treatment of functional erectile dysfunction-kidney yang deficiency syndrome
① 以安慰剂为对照,初步评价延藜胶囊治疗功能性勃起功能障碍-肾阳虚证的有效性。 ② 初步评价延藜胶囊在功能性勃起功能障碍-肾阳虚证患者中使用的安全性。
[Translation] ① Using placebo as control, preliminarily evaluate the effectiveness of Yanli Capsule in the treatment of functional erectile dysfunction-kidney yang deficiency syndrome. ② Preliminarily evaluate the safety of Yanli Capsule in patients with functional erectile dysfunction-kidney yang deficiency syndrome.
延藜胶囊治疗功能性勃起功能障碍(肾阳虚证)随机、双盲、安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial of Yanli Capsule in the treatment of functional erectile dysfunction (kidney yang deficiency syndrome)
初步评价延藜胶囊治疗功能性勃起功能障碍(肾阳虚证)有效性与安全性。
[Translation] To preliminarily evaluate the efficacy and safety of Yanli Capsule in the treatment of functional erectile dysfunction (kidney yang deficiency syndrome).
100 Clinical Results associated with Jiangxi Juwang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Jiangxi Juwang Pharmaceutical Co., Ltd.
100 Deals associated with Jiangxi Juwang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Jiangxi Juwang Pharmaceutical Co., Ltd.